https://www.selleckchem.com/products/cx-5461.html
for comparative effectiveness studies of reference G-CSFs and their biosimilars. Readily available BBCIC DRN data can be used to assess G-CSF use with the incidence of FN hospitalizations. Insufficient laboratory result data were available to report absolute neutrophil counts; however, other safety data are available for assessment that provide valuable baseline data regarding the effectiveness and safety of G-CSFs in preparation for comparative effectiveness studies of reference G-CSFs and their biosimilars.The use of appearance (versu
Like
Comment
Share
